{"result": "(\"entity\"<|>FRAILTY<|>EVENT<|>Frail condition characterized by decreased physical function and associated with various physiological alterations in the elderly)\n##\n(\"entity\"<|>SARCOPENIA<|>EVENT<|>Sarcopenia is the loss of muscle mass and strength, often associated with aging and linked to frailty)\n##\n(\"entity\"<|>DHEA-S<|>PERSON<|>Dehydroepiandrosterone sulfate, a hormone whose levels decrease with aging and is associated with frailty)\n##\n(\"entity\"<|>IGF-I<|>PERSON<|>Insulin-like growth factor 1, a hormone that decreases with aging and is related to muscle mass and strength)\n##\n(\"entity\"<|>IL-6<|>PERSON<|>Interleukin 6, a cytokine involved in inflammation that is associated with frailty)\n##\n(\"entity\"<|>IL-1<|>PERSON<|>Interleukin 1, a cytokine that plays a role in inflammatory responses and is linked to frailty)\n##\n(\"entity\"<|>FNT-α<|>PERSON<|>Tumor necrosis factor alpha, a cytokine involved in systemic inflammation and associated with frailty)\n##\n(\"entity\"<|>ALBUMIN<|>PERSON<|>A protein whose synthesis is negatively influenced by elevated levels of IL-6, related to muscle health)\n##\n(\"entity\"<|>FIBRINOGEN<|>PERSON<|>A blood plasma protein that is involved in coagulation and is influenced by inflammatory cytokines)\n##\n(\"entity\"<|>MUSCULOSKELETAL SYSTEM<|>PERSON<|>The system that includes muscles and bones, which is affected by hormonal changes during aging)\n##\n(\"relationship\"<|>FRAILTY<|>SARCOPENIA<|>Frailty and sarcopenia are interconnected conditions that share low physical capacity as a common attribute<|>8)\n##\n(\"relationship\"<|>DHEA-S<|>FRAILTY<|>Dehydroepiandrosterone sulfate levels decrease with aging, contributing to the development of frailty<|>6)\n##\n(\"relationship\"<|>IGF-I<|>FRAILTY<|>Insulin-like growth factor 1 is associated with muscle mass and strength, which are critical in frailty<|>6)\n##\n(\"relationship\"<|>IL-6<|>FRAILTY<|>Interleukin 6 is linked to inflammation and is associated with the frail condition<|>7)\n##\n(\"relationship\"<|>IL-1<|>FRAILTY<|>Interleukin 1 is involved in inflammatory responses that contribute to frailty<|>7)\n##\n(\"relationship\"<|>FNT-α<|>FRAILTY<|>Tumor necrosis factor alpha is a cytokine that plays a role in inflammation related to frailty<|>7)\n##\n(\"relationship\"<|>ALBUMIN<|>FRAILTY<|>Albumin synthesis is negatively influenced by elevated IL-6 levels, which is related to frailty<|>5)\n##\n(\"relationship\"<|>FIBRINOGEN<|>FRAILTY<|>Fibrinogen levels are influenced by inflammatory cytokines, which are associated with frailty<|>5)\n##\n(\"relationship\"<|>MUSCULOSKELETAL SYSTEM<|>FRAILTY<|>The musculoskeletal system is affected by hormonal changes during aging, contributing to frailty<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: AS ESPECÍFICAS\n\ndesnutrición y la sarcopenia, con sus alteraciones me-\ntabólicas asociadas25. Los más implicados en la fisiopa-\ntología de la fragilidad son los sistemas inmunológico,\nneuroendocrino y musculoesquelético (figura 3).\n\n* Sistema inmune: Se ha encontrado una asociación\nentre fragilidad, un estado proinflamatorio y la\nactivación de la cascada de la coagulación26, 27.\nDestacan, entre otras, la IL-6, la IL-1 y el FNT-α.\nTambién se han involucrado sus receptores, como\nel antagonista del receptor de la IL-1 y los recep-\ntores solubles del FNT. Los niveles elevados de IL-6\nprovocan catabolismo acelerado de proteínas,\nademás de inducir la síntesis de otras, como la\nproteína C reactiva, las haptoglobinas, el fibrinó-\ngeno, el factor VIII y el dímero D; e influye de for-\nma negativa en la síntesis de algunas, como la al-\nbúmina.\n\n* Sistema neuroendocrino: Con el envejecimiento\nocurren múltiples cambios hormonales cuya diana\nes el sistema musculoesquelético, que se han rela-\ncionado con la aparición de fragilidad. Destacan\nniveles bajos del factor de crecimiento insulínico\ntipo 1 (IGF-I), de dehidroepiandrosterona sulfato\n(DHEA-S) y de vitamina D28, 29. Durante el envejeci-\nmiento se produce disminución de hormonas\nanabólicas, que se relaciona con la fragilidad y la\npérdida involuntaria de músculo esquelético. Los\nandrógenos y la hormona del crecimiento están\n\nasociados a la MME y a la fuerza, por lo que su\ndisminución tiene un papel importante en el desa-\nrrollo de la fragilidad28. La disminución de la tes-\ntosterona ha sido el principal factor asociado con\nla pérdida de la masa y fuerza muscular debido al\nenvejecimiento29. Esta disminución se asocia a dis-\ncapacidad y a la pérdida de la fuerza de los miem-\nbros inferiores.\n\nTanto la fragilidad como la sarcopenia son la vía co-\nmún final de muchos procesos patológicos (figura 4).\nAdemás, la fragilidad también comparte con la sarco-\npenia la disminución del músculo esquelético como\ncaracterística clave. Por lo tanto, ambas condiciones\ncomparten la baja capacidad física como un atributo\ncomún30, y casi todas las definiciones de sarcopenia y\nfragilidad incluyen baja función física como compo-\nnente principal.\n\n2.5. Diagnóstico de fragilidad\n\nExisten múltiples herramientas para el diagnóstico\nde la fragilidad, y de hecho, en los estudios publicados\nen la literatura, es difícil encontrar una definición es-\ntándar31. Sin duda, los criterios diagnósticos más utili-\nzados han sido los de Fried7, apropiados para la defini-\nción de un fenotipo clínico. Otra estrategia diagnóstica\nforma parte del denominado modelo acumulativo uti-\nlizado por Rockwood, posteriormente resumido en sie-\n\n| Alteraciones fisiológicas | Fragilidad clínica |\n|---------------------------|---------------------|\n| ↑PCR<br>↑IL-6, IL-1, FNT-α | |\n| Inflamación | |\n| | Anorexia<br>Sarcopenia<br>Osteopenia<br>↓Función inmunológica<br>↓Cognición<br>↑Coagulación<br>↓Metabolismo de la glucosa | Debilidad<br>↓Velocidad de la marcha<br>Fatiga |\n| Disregulación<br>neuroendocrina | |\n| ↓IGF-1<br>↓DHEA-S<br>↑Cortisol | |\n\nDHEA-S: dehidroepiandrosterona sulfato; FNT: factor de necrosis tumoral; IGF-1: factor de crecimiento\ndependiente de insulina tipo 1; IL-1: interleucina 1; IL-6: interleucina 6; PCR: proteína C reactiva.\n\nFigura 3. Fisiopatología de la fragilidad.\n---\nTema 33. Sarcopenia y fragilidad en el anciano 531\n\n| SARCOPENIA | ALTERACIÓN DE LA FUNCIÓN FÍSICA | FRAGILIDAD |\n|------------|----------------------------------|------------|\n| ↓MME | ↓Fuerza muscular | -Suma de déficits |\n| -Baja calidad muscular | ↓Velocidad de la marcha | -Fatiga |\n| | ↓Equilibrio | -Sedentarismo |\n| | | -Pérdida de peso |\n| | | -Alteración cognitiva |\n| | | -Aislamiento social |\n\nM\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}